Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
CNS Drugs
Published in: CNS Drugs 3/1997

01-03-1997 | Review Articles

Inflammatory Cytokines in the CNS

Possible Role in the Pathogenesis of Neurodegenerative Disorders and Therapeutic Implications

Authors: Dr Edith G. McGeer, Patrick L. McGeer

Published in: CNS Drugs | Issue 3/1997

Login to get access
Metadata
Title
Inflammatory Cytokines in the CNS
Possible Role in the Pathogenesis of Neurodegenerative Disorders and Therapeutic Implications
Authors
Dr Edith G. McGeer
Patrick L. McGeer
Publication date
01-03-1997
Publisher
Springer International Publishing
Published in
CNS Drugs / Issue 3/1997
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI
https://doi.org/10.2165/00023210-199707030-00005

Other articles of this Issue 3/1997

CNS Drugs 3/1997 Go to the issue

Disease Management

Reversal of Opioid Intoxication

Review Articles

Aphasia

Disease Management

Obsessive-Compulsive Disorder

Adis Drug Evaluation

Iohexol

Leading Article

GABAB Receptors